R Dirk Allison Sells 12,500 Shares of Addus HomeCare Co. (NASDAQ:ADUS) Stock

Addus HomeCare Co. (NASDAQ:ADUSGet Free Report) CEO R Dirk Allison sold 12,500 shares of the firm’s stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the completion of the transaction, the chief executive officer now directly owns 141,897 shares of the company’s stock, valued at $17,476,034.52. This represents a 8.10 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Addus HomeCare Stock Up 1.2 %

Shares of NASDAQ:ADUS opened at $124.41 on Wednesday. Addus HomeCare Co. has a 12-month low of $85.43 and a 12-month high of $136.12. The firm has a fifty day moving average of $128.07 and a two-hundred day moving average of $123.41. The firm has a market capitalization of $2.26 billion, a P/E ratio of 28.47, a price-to-earnings-growth ratio of 2.17 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last released its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business had revenue of $289.80 million during the quarter, compared to analyst estimates of $289.42 million. During the same quarter in the previous year, the business earned $1.03 EPS. Addus HomeCare’s quarterly revenue was up 7.1% compared to the same quarter last year. Equities research analysts expect that Addus HomeCare Co. will post 4.58 earnings per share for the current fiscal year.

Analyst Ratings Changes

ADUS has been the subject of a number of recent analyst reports. Stephens raised their price objective on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 6th. TD Cowen raised their price objective on shares of Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a research note on Thursday, August 8th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $136.00 price objective on shares of Addus HomeCare in a research note on Thursday, November 14th. Macquarie reaffirmed an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a research note on Monday, November 4th. Finally, KeyCorp assumed coverage on shares of Addus HomeCare in a research note on Friday, October 11th. They set an “overweight” rating and a $150.00 target price for the company. One analyst has rated the stock with a sell rating, eight have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $131.63.

View Our Latest Stock Report on ADUS

Institutional Investors Weigh In On Addus HomeCare

Several institutional investors and hedge funds have recently modified their holdings of the business. Hohimer Wealth Management LLC acquired a new stake in shares of Addus HomeCare in the 3rd quarter valued at $299,000. Geode Capital Management LLC raised its holdings in Addus HomeCare by 7.1% in the 3rd quarter. Geode Capital Management LLC now owns 423,934 shares of the company’s stock worth $56,406,000 after acquiring an additional 28,284 shares during the period. Barclays PLC raised its holdings in Addus HomeCare by 204.8% in the 3rd quarter. Barclays PLC now owns 43,470 shares of the company’s stock worth $5,783,000 after acquiring an additional 29,207 shares during the period. EP Wealth Advisors LLC bought a new position in Addus HomeCare in the 3rd quarter worth $249,000. Finally, State Street Corp raised its holdings in Addus HomeCare by 4.4% in the 3rd quarter. State Street Corp now owns 663,610 shares of the company’s stock worth $88,280,000 after acquiring an additional 27,990 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

About Addus HomeCare

(Get Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

See Also

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.